Free Trial

Fresenius Medical Care (FMS) Competitors

$20.69
-0.81 (-3.77%)
(As of 10:45 AM ET)

FMS vs. DVA, SHC, AGL, PGNY, VMD, CO, OTRK, MRAI, MGRX, and BRTX

Should you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include DaVita (DVA), Sotera Health (SHC), agilon health (AGL), Progyny (PGNY), Viemed Healthcare (VMD), Global Cord Blood (CO), Ontrak (OTRK), Marpai (MRAI), Mangoceuticals (MGRX), and BioRestorative Therapies (BRTX). These companies are all part of the "miscellaneous health & allied services, not elsewhere classified" industry.

Fresenius Medical Care vs.

Fresenius Medical Care (NYSE:FMS) and DaVita (NYSE:DVA) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

DaVita received 87 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.80% of users gave DaVita an outperform vote while only 54.11% of users gave Fresenius Medical Care an outperform vote.

CompanyUnderperformOutperform
Fresenius Medical CareOutperform Votes
408
54.11%
Underperform Votes
346
45.89%
DaVitaOutperform Votes
495
61.80%
Underperform Votes
306
38.20%

In the previous week, DaVita had 3 more articles in the media than Fresenius Medical Care. MarketBeat recorded 8 mentions for DaVita and 5 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 0.75 beat DaVita's score of 0.70 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DaVita
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

8.3% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 2.0% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

DaVita has lower revenue, but higher earnings than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care$21.05B0.60$540.07M$0.8924.17
DaVita$12.14B1.03$691.53M$8.8016.22

Fresenius Medical Care has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, DaVita has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

Fresenius Medical Care currently has a consensus target price of $24.00, indicating a potential upside of 11.58%. DaVita has a consensus target price of $144.67, indicating a potential upside of 1.38%. Given Fresenius Medical Care's higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than DaVita.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14
DaVita
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

DaVita has a net margin of 6.61% compared to Fresenius Medical Care's net margin of 2.48%. DaVita's return on equity of 68.52% beat Fresenius Medical Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care2.48% 5.29% 2.30%
DaVita 6.61%68.52%4.98%

Summary

DaVita beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.

Get Fresenius Medical Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

MetricFresenius Medical Carehealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$12.62B$2.31B$5.33B$17.66B
Dividend Yield2.10%2.10%2.83%3.58%
P/E Ratio24.1717.49179.4025.20
Price / Sales0.606.422,272.8814.41
Price / Cash4.5611.4634.5619.23
Price / Book0.793.814.964.98
Net Income$540.07M$74.19M$110.10M$976.96M
7 Day Performance0.51%-0.60%-0.11%0.34%
1 Month Performance-0.83%1.74%0.48%-1.05%
1 Year Performance-6.23%-22.20%1.23%8.62%

Fresenius Medical Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DVA
DaVita
2.8869 of 5 stars
$143.03
-0.6%
$144.67
+1.1%
+47.0%$12.61B$12.14B16.2570,000Short Interest ↑
SHC
Sotera Health
3.4074 of 5 stars
$12.18
-2.6%
$16.92
+38.9%
-19.2%$3.54B$1.05B64.113,000
AGL
agilon health
1.5366 of 5 stars
$6.80
flat
$9.03
+32.8%
-67.2%$2.80B$4.32B-9.711,117Positive News
PGNY
Progyny
4.4107 of 5 stars
$27.60
-1.2%
$43.11
+56.2%
-29.8%$2.66B$1.09B45.25563Positive News
VMD
Viemed Healthcare
3.2628 of 5 stars
$7.20
-2.3%
N/A-25.6%$286.11M$183.01M27.691,030Short Interest ↓
Positive News
Gap Up
CO
Global Cord Blood
0 of 5 stars
$1.23
flat
N/A+7.9%$149.51M$1.24B1.921,202Gap Down
OTRK
Ontrak
2.976 of 5 stars
$0.23
-4.2%
$4.00
+1,661.3%
-92.0%$11.54M$12.74M-0.06102Short Interest ↓
Positive News
Gap Down
MRAI
Marpai
2.3764 of 5 stars
$0.83
-17.0%
$6.00
+622.9%
-63.6%$10.31M$37.15M-0.26162Gap Up
MGRX
Mangoceuticals
0 of 5 stars
$0.43
+13.2%
N/A-77.8%$9.48M$730,000.000.003Short Interest ↑
BRTX
BioRestorative Therapies
2.4914 of 5 stars
$1.16
-1.7%
N/AN/A$7.99M$145,800.00-0.3311Analyst Forecast
Short Interest ↓
News Coverage
Gap Up

Related Companies and Tools

This page (NYSE:FMS) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners